MA, P., L, L., Q, L., J, Z., MD, H., JM, L., & RE, M. (2021). In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms. JAC-antimicrobial resistance, 3(4), dlab177. https://doi.org/10.1093/jacamr/dlab177
Chicago Style (17th ed.) CitationMA, Pfaller, Li L, Liu Q, Zhang J, Huband MD, Lindley JM, and Mendes RE. "In Vitro Activity of a Novel Aminomethylcycline Antibacterial (KBP-7072), a Third-generation Tetracycline, Against Clinical Isolates with Molecularly Characterized Tetracycline Resistance Mechanisms." JAC-antimicrobial Resistance 3, no. 4 (2021): dlab177. https://doi.org/10.1093/jacamr/dlab177.
MLA (9th ed.) CitationMA, Pfaller, et al. "In Vitro Activity of a Novel Aminomethylcycline Antibacterial (KBP-7072), a Third-generation Tetracycline, Against Clinical Isolates with Molecularly Characterized Tetracycline Resistance Mechanisms." JAC-antimicrobial Resistance, vol. 3, no. 4, 2021, p. dlab177, https://doi.org/10.1093/jacamr/dlab177.